A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins

This publication has 27 references indexed in Scilit:

• Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
  Hepatology, 2004
• Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells
  Oncogene, 2003
• Molecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells
  Archives of Biochemistry and Biophysics, 2002
• Green Tea Constituent (−)-Epigallocatechin-3-gallate Inhibits Topoisomerase I Activity in Human Colon Carcinoma Cells
  Biochemical and Biophysical Research Communications, 2001
• Green Tea and Its Catechins Inhibit Breast Cancer Xenografts
  Nutrition and Cancer, 2001
• Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention
  BioFactors, 2000
• Green Tea and Its Major Components Ameliorate Immune Dysfunction in Mice Bearing Lewis LungCarcinoma and Treated With the Carcinogen NNK
  Nutrition and Cancer, 1999
• Induction of apoptosis in human stomach cancer cells by green tea catechins.
  Oncology Reports, 1998
• Cancer-Preventive Effects of Drinking Green Tea among a Japanese Population
  Preventive Medicine, 1997
• Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC
  Liver International, 1987